Consolidated Statements of Stockholders' (Deficit) Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Treasury Stock	Noncontrolling Interests in Subsidiaries	Total
Balance at Dec. 25, 2016	$ 441	$ 172,573	$ (5,887)	$ 219,278	$ (390,316)	$ 13,712	$ 9,801
Balance (in shares) at Dec. 25, 2016	36,683,000
Net income				102,292		2,038	104,330
Other comprehensive income (loss)			3,770				3,770
Cash dividends on common stock		136		(30,728)			(30,592)
Exercise of stock options	$ 1	6,259					$ 6,260
Exercise of stock options (in shares)	147,000						147,000
Tax effect of restricted stock awards		(2,428)					$ (2,428)
Acquisition of Company common stock					(209,586)		(209,586)
Acquisition of Company common stock (in shares)	(2,960,000)
Stock-based compensation expense		10,413					10,413
Issuance of restricted stock		(2,427)			2,427
Issuance of restricted stock (in shares)	54,000
Change in redemption value of noncontrolling interests				1,419			1,419
Contributions from noncontrolling interests						2,956	2,956
Distributions to noncontrolling interests						(2,949)	(2,949)
Other		259		(10)	403		652
Other (in shares)	7,000
Balance at Dec. 31, 2017	$ 442	184,785	(2,117)	292,251	(597,072)	15,757	(105,954)
Balance (in shares) at Dec. 31, 2017	33,931,000
Cumulative effect of adoption of ASU 2014-09				(24,359)			(24,359)
Adjusted balance	$ 442	184,785	(2,117)	267,892	(597,072)	15,757	(130,313)
Net income				2,474		1,874	4,348
Other comprehensive income (loss)			(571)				(571)
Adoption of ASU 2018-02			(455)	455
Cash dividends on common stock		145		(28,944)			(28,799)
Exercise of stock options	$ 1	2,698					$ 2,699
Exercise of stock options (in shares)	75,000						75,000
Tax effect of restricted stock awards		(1,521)					$ (1,521)
Acquisition of Company common stock					(158,049)		(158,049)
Acquisition of Company common stock (in shares)	(2,697,000)
Stock-based compensation expense		9,936					9,936
Issuance of restricted stock		(3,005)			3,005
Issuance of restricted stock (in shares)	56,000
Distributions to noncontrolling interests						(2,406)	(2,406)
Other		(54)		305	412		663
Other (in shares)	7,000
Balance at Dec. 30, 2018	$ 443	192,984	(3,143)	242,182	(751,704)	15,225	(304,013)
Balance (in shares) at Dec. 30, 2018	31,372,000
Net income				4,866		1,310	6,176
Other comprehensive income (loss)			(7,042)				(7,042)
Cash dividends on common stock		209		(28,761)			(28,552)
Cash dividends on preferred stock				(10,020)			(10,020)
Dividends declared on preferred stock				(2,273)			(2,273)
Exercise of stock options	$ 4	16,006					$ 16,010
Exercise of stock options (in shares)	447,000						448,000
Tax effect of restricted stock awards		(1,433)					$ (1,433)
Stock-based compensation expense		15,303					15,303
Issuance of restricted stock		(3,681)			3,681
Issuance of restricted stock (in shares)	63,000
Distributions to noncontrolling interests						(870)	(870)
Other		(341)		(297)	696		58
Other (in shares)	12,000
Balance at Dec. 29, 2019	$ 447	$ 219,047	$ (10,185)	$ 205,697	$ (747,327)	$ 15,665	$ (316,656)
Balance (in shares) at Dec. 29, 2019	31,894,000